The efficacy of tixagevimab–cilgavimab prophylaxis against Omicron BA.5 variants in patients with hematological malignancies: insights from the Leukemia and Lymphoma Society Registry.

Autor: Luttwak, Efrat1 (AUTHOR), Noy, Ariela1,2 (AUTHOR), Seshan, Venkatraman3 (AUTHOR), Saltzman, Larry A.4 (AUTHOR), Greenberger, Lee M.4 (AUTHOR)
Zdroj: Leukemia & Lymphoma. Oct2023, Vol. 64 Issue 10, p1727-1729. 3p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje
načítá se...